A history of breast cancer is not a contraindication to Mounjaro, but the decision requires individualised assessment and consultation with your oncology team
Retatrutide is a novel triple-agonist peptide developed by Eli Lilly, targeting GIP, GLP-1, and glucagon receptors, showing significant promise in clinical trials for obesity and type 2 diabetes due to its potent effects on appetite, energy expenditure, and glycemic control
How the Melanotan II calculation works Melanotan II is labelled in milligrams per vial
In T1DM, compounds like Irisin activate the SIRT1-p53-SLC7A11/GPX4 axis to protect -cells
Discussion As predicted, we found that the HT treatment significantly reduced plant height, stem diameter, shoot fresh weight, shoot dry weight, and shoot water content of cucumber, similar to some previous studies (e.g., Wahid et al
The current gold standard Tirzepatide (popularly known as Mounjaro or Zepbound )is already changing lives in our clinic